Asensus Surgical Inc. has made a thrilling leap forward in medical technology with the CE Mark approval of expanded machine vision capabilities on the previously-cleared Intelligent Surgical Unit™ (ISU™). With this approval, remote surgeons can now enjoy the benefits of Performance-Guided Surgery™ in Europe, Japan, and the United States. Senhance® Surgical System is also one of the first robotic surgical systems to be approved through the EU Medical Device Regulation (MDR) process, further revolutionizing the medical field.
We are delighted to offer pioneering ISU capabilities to surgeons in the EU! Surgeons have responded enthusiastically to the expanded feature set across the US and Japan, and we are eager to collaborate with new and existing customers to bring the most advanced real-time intraoperative digital tools into European operating rooms. This marks a pivotal moment for the company, as our filing went through a rigorous review of the Senhance Surgical System (hardware and software) under the new EU MDR process. Remarkably, Senhance was one of the first robotic platforms to be approved in the new process, taking only about a year. It is a testament to the hard work and dedication of our team and the quality of our technology.
The latest version of ISU features a suite of advanced features to make your surgical experience smoother than ever before. Enhance your intraoperative camera control with real-time data and make precise 3D measurements. Bring your images to life with image enhancement and digital tagging capabilities. Get the most out of your surgery with ISU.
Prof. Dietmar Stephan of St. Marien-krankenhaus Siegen in Germany has already experienced the power and potential of the first generation of the Intelligent Surgical Unit (ISU) with the Senhance Surgical System, which facilitates human-machine interaction and endoscopic camera control with ease. Now, with the new and improved second generation of ISU features, surgeons will be able to benefit from an even greater level of support and assistance during their operations. This includes real-time measurement tools with wide-ranging applications in surgery, and digital tagging that allows for easier communication between the console and tableside when it comes to identifying and marking critical structures such as clipping points or staple lines. With these advanced features, the Senhance Surgical System is sure to cement its place as a leader in the field of augmented intelligence in surgical robotics.
The Company is proud to announce the approval of expanded augmented intelligence features, which demonstrate a commitment to Performance-Guided Surgery. Surgeons of all specialties and procedures can benefit from the meaningful support these features provide. What’s more, the foundational elements of these features open the door to even more novel augmented intelligence capabilities in the future, enabled by the ISU’s vast potential.
About Asensus Surgical, Inc.
Asensus Surgical, Inc. is transforming the relationship between surgeon and patient with its revolutionary Performance-Guided Surgery. Our Digital Laparoscopy, Senhance Surgical System, and Intelligent Surgical Unit (ISU) are using machine vision, augmented intelligence, and deep learning to create a new standard of surgery with consistently superior outcomes. We are tackling the current shortcomings of surgical outcomes and value-based healthcare to revolutionize the way healthcare is delivered.